| Pharmaceutical active ingredients: |
| Insulin Zinc Suspension Human monocomponent crystalline |
| Available forms, composition and doses of Biohulin Ultralenta: |
| N / A |
| Biohulin Ultralenta medical category: |
| Human:Insulin preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10AB01 - Insulin (Human)A10AC01 - Insulin (Human)A10AD01 - Insulin (Human)A10AE01 - Insulin (Human)A10AF01 - Insulin (Human) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novo Nordisk |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Insulin Ultratard HM | Insulin Zinc Suspension Human crystalline | Novo Nordisk |
| Ultratard HM | Insulin Zinc Suspension Human crystalline | Novo Nordisk; JDH Pharmaceutical |
| Biohulin Lenta | Insulin Zinc Suspension Human monocomponent | Novo Nordisk |
| Novolin U | Insulin Zinc Suspension Human monocomponent | Novo Nordisk |
| Monotard HM | Insulin Zinc Suspension Human monocomponent amorphous; Insulin Zinc Suspension Human monocomponent crystalline | Novo Nordisk; JDH Pharmaceutical |
| Human Monotard | Insulin Zinc Suspension Human recombinant | Novo Nordisk |
| Insulina Humulin L | Insulin Zinc Suspension Human recombinant | Eli Lilly |
| Monotard | Insulin Zinc Suspension Human recombinant | Novo Nordisk |
| Monotard Human | Insulin Zinc Suspension Human recombinant | Abbott |
| Novolin L | Insulin Zinc Suspension Human recombinant; Insulin Zinc Suspension Human semisynthetic purified | Novo Nordisk; Pisa Laboratorios; Roemmers-Klinos |